1 |
Billiet L, De Cock L, Sanchez Sanchez G, Mayer RL, Goetgeluk G, De Munter S, Pille M, Ingels J, Jansen H, Weening K, Pascal E, Raes K, Bonte S, Kerre T, Vandamme N, Seurinck R, Roels J, Lavaert M, Van Nieuwerburgh F, Leclercq G, Taghon T, Impens F, Menten B, Vermijlen D, Vandekerckhove B. Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage. J Exp Med 2023;220:e20220942. [PMID: 36939517 DOI: 10.1084/jem.20220942] [Reference Citation Analysis]
|
2 |
Watanabe R, Kadoba K, Tamamoto A, Murata K, Murakami K, Onizawa H, Fujii T, Onishi A, Tanaka M, Ito H, Morinobu A, Hashimoto M. CD8+ Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis. JCM 2023;12:2342. [DOI: 10.3390/jcm12062342] [Reference Citation Analysis]
|
3 |
Choi SJ, Koh JY, Rha MS, Seo IH, Lee H, Jeong S, Park SH, Shin EC. KIR(+)CD8(+) and NKG2A(+)CD8(+) T cells are distinct innate-like populations in humans. Cell Rep 2023;42:112236. [PMID: 36897779 DOI: 10.1016/j.celrep.2023.112236] [Reference Citation Analysis]
|
4 |
Xiong H, Cui M, Kong N, Jing J, Xu Y, Liu X, Yang F, Xu Z, Yan Y, Zhao D, Zou Z, Xia M, Cen J, Tan G, Huai C, Fu Q, Guo Q, Chen K. Cytotoxic CD161(-)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine 2023;90:104507. [PMID: 36893588 DOI: 10.1016/j.ebiom.2023.104507] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Garcia A, Dugast E, Shah S, Morille J, Lebrun-Frenay C, Thouvenot E, De Sèze J, Le Page E, Vukusic S, Maurousset A, Berger E, Casez O, Labauge P, Ruet A, Raposo C, Bakdache F, Buffels R, Le Frère F, Nicot A, Wiertlewski S, Gourraud PA, Berthelot L, Laplaud D. Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm 2023;10. [PMID: 36810163 DOI: 10.1212/NXI.0000000000200091] [Reference Citation Analysis]
|
6 |
Gärtner BC, Klemis V, Schmidt T, Sester M, Meyer T. Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses. Vaccines (Basel) 2023;11. [PMID: 36851359 DOI: 10.3390/vaccines11020482] [Reference Citation Analysis]
|
7 |
McClory SE, Bardhan O, Rome KS, Giles JR, Baxter AE, Xu L, Gimotty PA, Faryabi RB, Wherry EJ, Pear WS, Jordan MS. The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR (+) CD8 (+) effector state and its deletion improves checkpoint blockade. bioRxiv 2023:2023. [PMID: 36824931 DOI: 10.1101/2023.02.16.528833] [Reference Citation Analysis]
|
8 |
Mangani D, Yang D, Anderson AC. Learning from the nexus of autoimmunity and cancer. Immunity 2023;56:256-71. [PMID: 36792572 DOI: 10.1016/j.immuni.2023.01.022] [Reference Citation Analysis]
|
9 |
Chi X, Huang M, Tu H, Zhang B, Lin X, Xu H, Dong C, Hu X. Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections. Sci China Life Sci 2023. [PMID: 36738430 DOI: 10.1007/s11427-021-2187-3] [Reference Citation Analysis]
|
10 |
Seok J, Cho SD, Seo SJ, Park SH. Roles of Virtual Memory T Cells in Diseases. Immune Netw 2023;23:e11. [PMID: 36911806 DOI: 10.4110/in.2023.23.e11] [Reference Citation Analysis]
|
11 |
Vignali PDA, DePeaux K, Watson MJ, Ye C, Ford BR, Lontos K, McGaa NK, Scharping NE, Menk AV, Robson SC, Poholek AC, Rivadeneira DB, Delgoffe GM. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat Immunol 2023;24:267-79. [PMID: 36543958 DOI: 10.1038/s41590-022-01379-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
12 |
Koh JY, Kim DU, Moon BH, Shin EC. Human CD8(+) T-Cell Populations That Express Natural Killer Receptors. Immune Netw 2023;23:e8. [PMID: 36911797 DOI: 10.4110/in.2023.23.e8] [Reference Citation Analysis]
|
13 |
Mora-Bitria L, Asquith B. Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections. Immunogenetics 2023;:1-14. [PMID: 36719466 DOI: 10.1007/s00251-023-01293-w] [Reference Citation Analysis]
|
14 |
Nishide M, Nishimura K, Matsushita H, Edahiro R, Inukai S, Shimagami H, Kawada S, Kato Y, Kawasaki T, Tsujimoto K, Kamon H, Omiya R, Okada Y, Hattori K, Narazaki M, Kumanogoh A. Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis.. [DOI: 10.21203/rs.3.rs-2466890/v1] [Reference Citation Analysis]
|
15 |
Calderón-Parra J, Guisado-Vasco P, Montejano-Sánchez R, Estrada V, Cuevas-Tascón G, Aguareles J, Arribas J, Erro-Iribarren M, Calvo-Salvador M, Fernández-Cruz A, Ramos-Martínez A, Muñez-Rubio E. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort. J Clin Med 2023;12. [PMID: 36769511 DOI: 10.3390/jcm12030864] [Reference Citation Analysis]
|
16 |
Moon JS, Younis S, Ramadoss NS, Iyer R, Sheth K, Sharpe O, Rao NL, Becart S, Carman JA, James EA, Buckner JH, Deane KD, Holers VM, Goodman SM, Donlin LT, Davis MM, Robinson WH. Cytotoxic CD8(+) T cells target citrullinated antigens in rheumatoid arthritis. Nat Commun 2023;14:319. [PMID: 36658110 DOI: 10.1038/s41467-022-35264-8] [Reference Citation Analysis]
|
17 |
Edner NM, Ntavli E, Petersone L, Wang CJ, Fabri A, Kogimtzis A, Ovcinnikovs V, Ross EM, Heuts F, Elfaki Y, Houghton LP, Talbot T, Sheri A, Pender A, Chao D, Walker LSK. Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood. Immunother Adv 2023;3:ltad001. [PMID: 36818683 DOI: 10.1093/immadv/ltad001] [Reference Citation Analysis]
|
18 |
Sarangi SK, Lande KM, Kumar S. KIR signaling is regulated by electrostatic interaction of its cytosolic tail with the plasma membrane despite being neutral polyampholyte. Proc Natl Acad Sci U S A 2023;120:e2212987120. [PMID: 36574700 DOI: 10.1073/pnas.2212987120] [Reference Citation Analysis]
|
19 |
Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, Cervia C, Fennessy B, Mouskas K, Francoeur NJ, Johnson JS, Lepow L, Le Berichel J, Chang C, Beckmann AG, Wang YC, Nie K, Zaki N, Tuballes K, Barcessat V, Cedillo MA, Yuan D, Huckins L, Roussos P, Marron TU, Glicksberg BS, Nadkarni G, Heath JR, Gonzalez-Kozlova E, Boyman O, Kim-Schulze S, Sebra R, Merad M, Gnjatic S, Schadt EE, Charney AW, Beckmann ND; Mount Sinai COVID-19 Biobank Team. Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nat Med 2023;29:236-46. [PMID: 36482101 DOI: 10.1038/s41591-022-02107-4] [Reference Citation Analysis]
|
20 |
Vicentini C, Zotti CM, Cornio AR, Garlasco J, Marengo N, Meddis D, Ditommaso S, Giacomuzzi M, Memoli G, Bordino V, Gianino MM, On Behalf Of The Collaborating Group. Serological Responses up to 9 Months following COVID-19 mRNA Vaccination in Residents and Health-Care Workers of Long-Term Care Facilities: A Multicenter Prospective Cohort Study in Northern Italy. Vaccines (Basel) 2022;10. [PMID: 36560593 DOI: 10.3390/vaccines10122183] [Reference Citation Analysis]
|
21 |
Sly LM, McKay DM. Macrophage immunotherapy: overcoming impediments to realize promise. Trends Immunol 2022;43:959-68. [PMID: 36441083 DOI: 10.1016/j.it.2022.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
22 |
Viano ME, Baez NS, Savid-Frontera C, Lidon NL, Hodge DL, Herbelin A, Gombert JM, Barbarin A, Rodriguez-Galan MC. Virtual Memory CD8(+) T Cells: Origin and Beyond. J Interferon Cytokine Res 2022;42:624-42. [PMID: 36083273 DOI: 10.1089/jir.2022.0053] [Reference Citation Analysis]
|
23 |
Chitnis T, Kaskow BJ, Case J, Hanus K, Li Z, Varghese JF, Healy BC, Gauthier C, Saraceno TJ, Saxena S, Lokhande H, Moreira TG, Zurawski J, Roditi RE, Bergmark RW, Giovannoni F, Torti MF, Li Z, Quintana F, Clementi WA, Shailubhai K, Weiner HL, Baecher-Allan CM. Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. Front Immunol 2022;13:956907. [PMID: 36505477 DOI: 10.3389/fimmu.2022.956907] [Reference Citation Analysis]
|
24 |
Mooslechner AA, Schuller M, Artinger K, Kirsch AH, Schabhüttl C, Eller P, Rosenkranz AR, Eller K. Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8(+) T Cells. Cells 2022;11. [PMID: 36429085 DOI: 10.3390/cells11223656] [Reference Citation Analysis]
|
25 |
Chen W, Van Beusecum JP, Xiao L, Patrick DM, Ao M, Zhao S, Lopez MG, Billings FT 4th, Cavinato C, Caulk AW, Humphrey JD, Harrison DG. Role of Axl in target organ inflammation and damage due to hypertensive aortic remodeling. Am J Physiol Heart Circ Physiol 2022;323:H917-33. [PMID: 36083796 DOI: 10.1152/ajpheart.00253.2022] [Reference Citation Analysis]
|
26 |
Levescot A, Malamut G, Cerf-Bensussan N. Immunopathogenesis and environmental triggers in coeliac disease. Gut 2022;71:2337-49. [PMID: 35879049 DOI: 10.1136/gutjnl-2021-326257] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
27 |
Wang YY, Hu W, Wang FS, Zhang C. Revisiting the role of human memory CD8+ T cells in immune surveillance. Cell Mol Immunol 2022;19:1319-21. [PMID: 35922545 DOI: 10.1038/s41423-022-00900-2] [Reference Citation Analysis]
|
28 |
Dugast E, Shah S, Laplaud D. Single-Cell Analysis to Better Understand the Mechanisms Involved in MS. IJMS 2022;23:12142. [DOI: 10.3390/ijms232012142] [Reference Citation Analysis]
|
29 |
Hu D, Xia W, Weiner HL. CD8+ T cells in neurodegeneration: friend or foe? Mol Neurodegener 2022;17:59. [PMID: 36056406 DOI: 10.1186/s13024-022-00563-7] [Reference Citation Analysis]
|
30 |
Lokwani R, Ngo TB, Destefano S, Adusei KM, Bhuiyan M, Josyula A, Faust M, Lin A, Karkanitsa M, Fathi P, Sadtler K. The CD103-XCR1 axis mediates the recruitment of immunoregulatory dendritic cells after traumatic injury.. [DOI: 10.1101/2022.08.19.504399] [Reference Citation Analysis]
|
31 |
Palmer WH, Leaton LA, Codo AC, Hume PS, Crute B, Stone M, van Bokhoven A, Tobin RP, Mccarter MD, Janssen WJ, Roest J, Zhu S, Petersen J, Vivian JP, Rossjohn J, Trowsdale J, Getahun A, Cambier J, Loh L, Norman PJ. Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.. [DOI: 10.1101/2022.08.17.503789] [Reference Citation Analysis]
|
32 |
Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun 2022;:102870. [PMID: 35872102 DOI: 10.1016/j.jaut.2022.102870] [Reference Citation Analysis]
|
33 |
Chen L, Yue J, Zhang S, Bai W, Qin L, Zhang C, Wu B, Li M, Xu S, Jiang Q, Yang L, Xu Q, Zhu R, Xie M, Gong R. SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma. Front Immunol 2022;13:947724. [DOI: 10.3389/fimmu.2022.947724] [Reference Citation Analysis]
|
34 |
Rinaldo CR. Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection. AIDS 2022;36:1311-3. [PMID: 35833683 DOI: 10.1097/QAD.0000000000003284] [Reference Citation Analysis]
|
35 |
Pollock NR, Harrison GF, Norman PJ. Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health. J Allergy Clin Immunol Pract 2022;10:1763-75. [PMID: 35561968 DOI: 10.1016/j.jaip.2022.04.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
36 |
París-muñoz A, Aizpurua G, Barber DF. Helios Expression Is Downregulated on CD8+ Treg in Two Mouse Models of Lupus During Disease Progression. Front Immunol 2022;13:922958. [DOI: 10.3389/fimmu.2022.922958] [Reference Citation Analysis]
|
37 |
Hirai T, Yoshioka Y. Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses. Front Immunol 2022;13:918611. [DOI: 10.3389/fimmu.2022.918611] [Reference Citation Analysis]
|
38 |
Billiet L, De Cock L, Sanchez GS, Mayer RL, Goetgeluk G, De Munter S, Pille M, Ingels J, Jansen H, Weening K, Pascal E, Raes K, Bonte S, Kerre T, Vandamme N, Seurinck R, Roels J, Lavaert M, Van Nieuwerburgh F, Leclercq G, Taghon T, Impens F, Menten B, Vermijlen D, Vandekerckhhove B. Single-cell profiling identifies a spectrum of human unconventional intraepithelial T lineage cells.. [DOI: 10.1101/2022.05.24.492634] [Reference Citation Analysis]
|
39 |
Koh JY, Shin EC. KIRs mark killers suppressing autoimmunity. Immunity 2022;55:735-7. [PMID: 35545025 DOI: 10.1016/j.immuni.2022.04.014] [Reference Citation Analysis]
|
40 |
Hu D, Murugaiyan G. CD8+ Tregs kill pathogenic cells to avert autoimmunity. Trends in Immunology 2022. [DOI: 10.1016/j.it.2022.04.006] [Reference Citation Analysis]
|
41 |
Levescot A, Cerf-Bensussan N. Regulatory CD8+ T cells suppress disease. Science 2022;376:243-4. [PMID: 35420956 DOI: 10.1126/science.abp8243] [Reference Citation Analysis]
|
42 |
Bolivar-Wagers S, Larson JH, Jin S, Blazar BR. Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease. Front Immunol 2022;13:864748. [PMID: 35493508 DOI: 10.3389/fimmu.2022.864748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
43 |
Cadwell K, Dustin ML. Cellular Immunology: Overview – Introduction to Functional Cell Biology of Immunity. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00278-9] [Reference Citation Analysis]
|
44 |
Li J, Wilhelmy J, Davis MM. Characterization of KIR(+)CD8(+) Regulatory T Cells in Humans by scRNA- and TCR-seq. Methods Mol Biol 2022;2574:41-121. [PMID: 36087198 DOI: 10.1007/978-1-0716-2712-9_4] [Reference Citation Analysis]
|
45 |
Yoshimura A, Ohyagi M, Ito M. T cells in the brain inflammation. Advances in Immunology 2022. [DOI: 10.1016/bs.ai.2022.10.001] [Reference Citation Analysis]
|